Infliximab Can Improve Traumatic Brain Injury by Suppressing the Tumor Necrosis Factor Alpha Pathway
Authors (first, second and last of 5)

Molecular Neurobiology is an exciting journal for neuroscientists who wish to stay in close touch with progress at the forefront of contemporary molecular brain research. It is specifically designed to synthesize and critically assess research trends for all neuroscientists at the cutting edge of this dramatically developing area. The journal has proven to be crucial in departmental libraries, serving as essential reading for every committed neuroscientist striving to keep abreast of rapid developments in a forefront field. Each topic chosen for review is thoroughly analyzed by scientists and clinicians internationally renowned for their special competence in the areas treated.
Why publish with us
COVID-19 is a new coronavirus that has not been previously identified in humans. Previously called 2019-nCov or 2019 Novel Coronavirus, it was first reported in December 2019 in Wuhan, China.
The aim of this Special Issue is to shed light on the potential effects of COVID-19 on neurological function. This includes original research that examines the family of coronaviruses and neurological function in general.
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
© Springer Science+Business Media, LLC, part of Springer Nature